Xumanii, Inc. f/k/a Medora Corp (OTCMKTS:XUII) Drops Following Quarterly

In my article on Xumanii, Inc. f/k/a Medora Corp (OTCMKTS:XUII) from yesterday, I said there was a chance the price would drop back after the filing of the 10-Q last Friday.

XUII did in fact drop. It closed down 11.99% at $0.235 after 5.6 million shares had changed hands during the session.

The company managed to squeeze in another fluff press release around the open. XUII has supposedly begun the Engineering phase of some technology allowing the broadcast of live content in TrueHD. This technology is supposed to reduce the costs associated with current broadcast platforms.

Whether the market recognized the press release as nothing but hype, or the quarterly report had a sobering effect on believers, yesterday’s price action suggests some traders aren’t convinced XUII is worth its $80 million market cap.

Awesome Penny Stocks called yesterday’s performance consolidation. To the pumpers’ credit, XUII has survived a couple of days longer than most of their previous picks. However, talking about “the next big run up” is somewhat far-fetched.

XUII‘s song maybe all but sung. The eyes of most pump players on the OTC are captured by another stock these days. It’s Biozoom Inc (OTCBB:BIZM). The price has more than tripled since the stock started trading actively. As discussed in some articles, BIZM exhibits more than one characteristic of a pump scheme.